Stryker to sell OP-1 product line to Olympus

12/6/2010 |

Olympus is set to buy Stryker's OP-1 product portfolio, which includes the OP-1 bone growth putty and OP-1 implant, for $60 million. Stryker said the deal is "aligned with strategic objectives for both companies," and it plans to spend a part of its R&D budget for the product line on other research initiatives that "offer the potential for greater shareholder returns."

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT